PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment
- Wing Lam
- , Zaoli Jiang
- , Fulan Guan
- , Xiu Huang
- , Rong Hu
- , Jing Wang
- , Scott Bussom
- , Shwu Huey Liu
- , Hongyu Zhao
- , Yun Yen
- , Yung Chi Cheng
Research output: Contribution to journal › Article › peer-review
106
Link opens in a new tab
Citations
(Scopus)